openPR Logo
Press release

Behavioral Disorders Drug Development Pipeline Review, 2017

10-24-2017 06:26 PM CET | Health & Medicine

Press release from: ReportsWorldwide

Behavioral Disorders Drug Development Pipeline Review, 2017

Behavioral Disorders Drug Development Pipeline Review, 2017

ReportsWorldwide has announced the addition of a new report title Behavioral Disorders Drug Development Pipeline Review, 2017 to its growing collection of premium market research reports.

Summary
This report provides an overview of the behavioral disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for autism, obsessive-compulsive disorder and attention deficit hyperactivity disorder and features dormant and discontinued projects.

Autism, also known as complex developmental disability, is a neurodevelopment disorder characterized by social interaction, verbal and nonverbal communication and repetitive behaviors. Risk factors include child’s sex, family history, fragile X syndrome, Tourette syndrome and epilepsy.
Obsessive-compulsive disorder (OCD) is characterized by unreasonable thoughts and fears (obsessions) that lead to do repetitive behaviors (compulsions). Symptoms include having repeated thoughts or images about many different things, such as fear of germs, dirt, or intruders, acts of violence, hurting loved ones, doing the same rituals over and over such as washing hands, locking and unlocking doors, counting, keeping unneeded items, or repeating the same steps again and again.

Finally, attention deficit hyperactivity disorder (ADHD) is a group of behavioral symptoms that include inattentiveness, hyperactivity and impulsiveness. Symptoms of ADHD include disorganized work habits, procrastination and inability to sustain attention on tasks or activities.

The size of these pipelines ranges from 8 products in obsessive-compulsive disorder to 58 products in attention deficit hyperactivity disorder. Across all three of these indications, transporters and receptors of neurotransmitters such as dopamine, glutamine and serotonin, plus G protein-coupled receptors and ion channels, are the most common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for behavioral disorder therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of behavioral disorders?

To Get Sample Copy of Report please visit @ https://www.reportsworldwide.com/enquiry?report_id=41643

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

To view a detailed description and Table of Contents please visit: https://www.reportsworldwide.com/report/behavioral-disorders-drug-development-pipeline-review-2017

About ReportsWorldwide.com
ReportsWorldwide.com is a leading provider of global market intelligence reports and services. With research reports from top publishers, consulting and advisory firms, ReportsWorldwide.com offers instant online access to a growing database of expert insights on global industries, companies, products, geographies and trends.

Press Contact:
Abigail Crasto
Senior Vice President
101, Arch Street
Boston,
MA 02110
US
Phone +1 (617) 398-1947
abigail@reportsworldwide.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Behavioral Disorders Drug Development Pipeline Review, 2017 here

News-ID: 784062 • Views: 220

More Releases from ReportsWorldwide

World Deep Brain Stimulation Market Top Segments, Key Players Revenue, Growth Ra …
The World Deep Brain Stimulation Market is estimated to represent a global market of USD 751.8 million by 2017 with growth rate of 18.2%. Deep brain stimulation (DBS) procedure is primarily used for the treatment of neuropsychiatric disorders such as mood disorder, dementia, anxiety and others. The procedure involve the use of neurotransmitter (brain pacemaker) that enables to transmit electric impulses to the specific target of brain cells. Increasing incidence
New report explores the Gene Editing Market : Ushering The Next Breakthrough in …
Boston, MA ReportsWorldwide has announced the addition of a new report title Gene Editing The Next Breakthrough in Regenerative Medicine to its growing collection of premium market research reports. Genome editing is a type of genetic engineering in which DNA is replaced, inserted or deleted in a living organism's ggenome using engineered molecular scissors. Believed to be one of the great biotechnology breakthroughs, gene editing is a powerful tool in pharmaceutical research that
Global In-Building Wireless BTSController-based Small Cells Market Analysis and …
Boston, MA ReportsWorldwide has announced the addition of a new report title Global In-Building Wireless BTSController-based Small Cells Market Analysis and Forecast, 2017-2021 to its growing collection of premium market research reports. This report covers the leading in-building wireless enterprise BTS/controller-based small cells network equipment manufacturers: • CommScope/Airvana • Comba Telecom • Ericsson • Huawei Technologies • Nokia • SpiderCloud • ZTE Corporation This report covers the global market share for 2016 shipments as well as a forecast for 2017-2021. To view a detailed description and Table of
UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply …
Boston, MA ReportsWorldwide has announced the addition of a new report title UDAY’s Impact and Compatibility State wise indexing of Integrated Power Supply Chain in India – 2017 to its growing collection of premium market research reports. UDAY scheme was touted as the next paladin to bail out the struggling Discoms, in order to turn them green in a time horizon of 3-4 years from 2015/16. Though was optional for the

All 5 Releases


More Releases for Behavioral

Global Behavioral Biometrics Market – Forecasts to 2026
According to a new market research report published by Global Market Estimates, the Global Behavioral Biometrics Market is expected to grow at a CAGR of 24.05% during the forecast period, to reach USD 4872.93 Million by 2026. The demand for behavioral biometrics is projected to be high due to the increasing need for a multi-layered security approach in the finance vertical. Browse 140 Market Data Tables and 112 Figures spread through
Potential Impact of COVID-19 on Behavioral Therapy Market 2020 | Magellan Health …
A detailed study on 'Behavioral Therapy Market' formulated by Brandessence Market Research, puts together a concise analysis of the growth factors impacting the current business scenario across assorted regions. Significant information pertaining to the industry's size, share, application, and statistics are also summed in the report in order to present an ensemble prediction. In addition, this report undertakes an accurate competitive analysis illustrating the status of market majors in the
Behavioural Health Market Segmentation by 2028 | Behavioral Health Network Inc., …
According to the latest market report published by Future Market Insights titled “Behavioural Health Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028”, the global behavioural health market is expected to expand at 3.4% CAGR over the forecast period 2018-2028. North America is expected to hold the highest revenue share in the global behavioural health market over the forecast period. Currently, over 43.8 million adults in the U.S. are suffering from
Behavioral Therapy Market - Global Industry Analysis 2023.
Behavior therapy, also known as behavior analytical and psychotherapy, is a term that broadly refers to the treatment that helps alter self-destructing behaviors in a patient. It is sometimes also termed as cognitive behavioral therapy or behavioral modification. Those patients who practice behavior therapy usually learn behaviors and are more specific. Medical professionals perform behavior therapy to substitute bad habits with good ones. In addition, behavior therapy also helps to
Behavioral Rehabilitation Market Professional Survey Report 2017
Global Behavioral Rehabilitation Market: Overview The global behavioral rehabilitation market is driven by the growing awareness among people regarding the availability of therapeutic options. The prevalence of behavioral disorders is also increasing, driving the behavioral rehabilitation market. The growing efforts and initiatives taken by governments across the globe in this direction will also push the growth of this market. Some of the programs started by governments to help people affected
Predictions for 2023: Behavioral Therapy Market
Behavioral Therapy Market: Overview Behavior therapy, also known as behavior analytical and psychotherapy, is a term that broadly refers to the treatment that helps alter self-destructing behaviors in a patient. It is sometimes also termed as cognitive behavioral therapy or behavioral modification. Those patients who practice behavior therapy usually learn behaviors and are more specific. Medical professionals perform behavior therapy to substitute bad habits with good ones. In addition, behavior therapy